Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Legend Biotech's Johnson & Johnson-partnered CAR-T therapy Carvykti won an FDA go-ahead to challenge Bristol Myers Squibb's Abecma in multiple myeloma.
An FDA approval for Johnson & Johnson and Legend Biotech’s CAR-T therapy may be three months later than originally expected, but it still came through for the partners.
Ciltacabtagene autoleucel (cilta-cel) is indicated for patients with relapsed/refractory multiple myeloma who have already had many previous treatments.
Poseida Therapeutics has hired former Novartis Vice Presiden
The FDA's negative opinion toward Eli Lilly and Innovent Biologics' PD-1 application has broad implications for Chinese biopharmas eyeing the U.S. market and future PD-1/L1 programs. Novartis India plans to cut 400 jobs after a sales pact with Dr. Reddy's. Moderna will build four new commercial subsidiaries in Asia. And more.